Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer.

Authors :: Denis, Fabrice
Basch, Ethan
Septans, Anne-Lise
Bennouna, Jaafar
Urban, Thierry
Dueck, Amylou C.
Letellier, Christophe
Source :: JAMA: Journal of the American Medical Association. 1/22/2019, Vol. 321 Issue 3, p306-307. 2p.
Publication Year :: 2019
Abstract: This study reports 2-year survival outcomes among patients with advanced nonprogressive stage IIA to IV lung cancer randomized to symptom monitoring during chemotherapy via web-based patient-reported outcomes vs standard scheduled imaging after treatment to detect symptomatic recurrence. [ABSTRACT FROM AUTHOR]

Subjects :: *LUNG cancer
*PATIENT monitoring
*INTERNET in medicine
*CANCER treatment
*CANCER patients

Full Text Access

Tools